[ad_1]
The American president is convinced that the pharmaceutical companies wanted to harm him in the American elections.
Donald Trump talks about “corrupt games.”
Pfizer had played “corrupt games,” Donald Trump told a news conference at the White House on Friday. The president believes the drug company deliberately waited until after the election to announce that it had developed a vaccine. According to Trump for two reasons: first, because of Trump’s intention to lower drug prices, which he used to turn pharmaceutical companies against him. On the other hand, hurting him in the American elections.
“Big pharmaceutical companies have invested millions in vilifying me in the election campaign. The electoral campaign that, by the way, I won. You’ll find out in a bit. Almost 74 million votes for me, ”said a president who has not yet admitted defeat.
In reality, according to Trump, the plan was for Pfizer to release the data in October, that is, before the election. “But they waited, they waited and they waited and then they decided to publish the results a few days after the elections.”
He also accused Pfizer of deliberately failing to publish the vaccine news in October.
REUTERS
Presumably, it would have had an impact on the election if Pfizer had made it public earlier, Trump said. “Maybe not. I’m sure the Democrats would have found these ballots somewhere.” But it will not stop you from doing what is right for the American people.
Pfizer has denied an intentional delay, according to the New York Post.
Emergency approval requested
Meanwhile, Biontech and Pfizer, according to their own statements, have applied for emergency approval for their coronavirus vaccine with the US Food and Drug Administration.Pfizer confirmed this on Friday (local time) on Twitter. If approved by US authorities, they are now ready to begin administering the vaccine in a few hours, it said Friday.
Pfizer has also started filing applications with other health authorities around the world. It was also said that more permit applications should follow. If the active ingredient is approved, particularly vulnerable people in the United States could be vaccinated in mid to late December.
